Cannabis use history was associated with longer delays before psychosis treatment

In 33 first-episode psychosis patients, cannabis use history was a significant predictor of longer duration of untreated psychosis in a multivariate model that also included age and negative symptoms.

Souaiby, Lama et al.·Early intervention in psychiatry·2019·Preliminary EvidenceProspective Cohort
RTHC-02302Prospective CohortPreliminary Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Prospective Cohort
Evidence
Preliminary Evidence
Sample
N=33

What This Study Found

No single sociodemographic or disease factor predicted duration of untreated psychosis (DUP) individually except education level. In multivariate analysis, age at inclusion, negative symptoms, and cannabis use history significantly predicted longer DUP.

Key Numbers

33 patients studied. Cannabis use, age, and negative symptoms were significant predictors of DUP in multivariate analysis. No other individual factors were significant.

How They Did This

Prospective study of 33 consecutive patients crossing the CAARMS psychosis threshold at a specialized early detection clinic in Paris. DUP and cannabis history assessed through comprehensive interviews of patients, parents, and practitioners.

Why This Research Matters

Longer DUP is associated with worse long-term outcomes in psychosis. If cannabis use contributes to delayed treatment-seeking, this is a modifiable factor that early intervention programs should address.

The Bigger Picture

Cannabis users with emerging psychosis may be less likely to seek help, possibly because cannabis provides perceived symptom relief, reduces insight into illness, or exists in a social context where help-seeking is less likely.

What This Study Doesn't Tell Us

Very small sample (n=33). Single-center study in Paris. DUP measurement depends on accurate recall of symptom onset. Multivariate model with three predictors in 33 subjects has limited statistical power.

Questions This Raises

  • ?Does cannabis reduce insight into psychotic symptoms?
  • ?Would cannabis-focused outreach reduce DUP?
  • ?Are cannabis-using patients referred to treatment through different pathways than non-users?

Trust & Context

Key Stat:
Cannabis use predicted longer duration of untreated psychosis
Evidence Grade:
Preliminary: small prospective study (n=33) from a single site.
Study Age:
Published in 2019.
Original Title:
Individual factors influencing the duration of untreated psychosis.
Published In:
Early intervention in psychiatry, 13(4), 798-804 (2019)
Database ID:
RTHC-02302

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Enrolls participants and follows them forward in time.

What do these levels mean? →

Frequently Asked Questions

What is duration of untreated psychosis?

DUP is the time between when psychotic symptoms first appear and when treatment begins. Shorter DUP is consistently associated with better long-term outcomes in schizophrenia and related disorders.

Why might cannabis users delay treatment?

Cannabis may mask early psychotic symptoms, reduce motivation to seek help, or provide a social environment where unusual experiences are normalized rather than flagged as concerning.

Read More on RethinkTHC

Cite This Study

RTHC-02302·https://rethinkthc.com/research/RTHC-02302

APA

Souaiby, Lama; Gauthier, Claire; Kazes, Mathilde; Mam-Lam-Fook, Célia; Daban, Claire; Plaze, Marion; Gaillard, Raphaël; Krebs, Marie-Odile. (2019). Individual factors influencing the duration of untreated psychosis.. Early intervention in psychiatry, 13(4), 798-804. https://doi.org/10.1111/eip.12562

MLA

Souaiby, Lama, et al. "Individual factors influencing the duration of untreated psychosis.." Early intervention in psychiatry, 2019. https://doi.org/10.1111/eip.12562

RethinkTHC

RethinkTHC Research Database. "Individual factors influencing the duration of untreated psy..." RTHC-02302. Retrieved from https://rethinkthc.com/research/souaiby-2019-individual-factors-influencing-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.